The Transplantation Signature Program, led by Ronald Ferguson, MD, PhD, coordinates the clinical care of patients needing kidney, liver, pancreas, heart or lung transplants. This program also interfaces with the Cancer Signature Program (blood and marrow transplantation) and the Cornea Transplant Program.
Transplantation expertise at the Medical Center is consolidated in Ohio State’s Comprehensive Transplant Center (CTC), which was established in 2005 as the only comprehensive adult transplant program in central Ohio. The CTC combines the Medical Center’s more than 35 years of experience in solid organ transplantation with research advances that translate to innovative patient care. By creating a forum for collaboration among experts from multiple transplantation disciplines, the CTC team is able to transfer best practices across specialties to enhance care.
Transplantation Signature Program highlights of 2007
- 290 patients received solid organ transplants at Ohio State’s Medical Center, including 214 kidney, 28 liver, 23 kidney/ pancreas, five pancreas, seven lung and 14 heart transplants.
- Based on volume, the Medical Center’s kidney transplant program is tied for 11th in the nation, and its kidney-pancreas transplant program ranks fifth.
- The CTC has maintained multidisciplinary organ-specific patient care teams for sophisticated post-transplant clinical management.
- The CTC recruited Tushar Patel, MB, ChB, a gastroenterologist who serves as director of hepatology. Patel has clinical interests in liver disease and transplant, and in hepatobiliary
cancer.
- In collaboration with other disciplines, the CTC maintained National Institutes of Health (NIH) research funding at approximately $500,000 in total direct costs.
- The CTC hosted Ohio State’s second National Symposium on Transplant Critical Care
- CTC investigators initiated or maintained 17 separate clinical trials of innovative immunosuppressive strategies in organ transplant recipients.